Rapid recovery from acute, potentially lethal myocarditis.

Area of Science:

• Cardiology
• Immunology
• Internal Medicine

Background:

• Acute myocarditis is an inflammation of the heart muscle.
• Severe cases often present with poor prognostic indicators.
• Conventional treatments include medications like captopril and metoprolol.

Observation:

• Two young men with acute myocarditis and poor prognostic markers were treated conventionally.
• Intravenous immunoglobulin was added to their treatment regimen.
• Rapid clinical and laboratory improvements were observed post-immunoglobulin therapy.

Findings:

• The addition of intravenous immunoglobulin to conventional therapy correlated with rapid recovery.
• This suggests a potential benefit of immunomodulatory treatment in severe acute myocarditis.
• The findings support prior, less conclusive, evidence on autoimmune treatment for myocarditis.

Implications:

• Intravenous immunoglobulin may be a valuable therapeutic option for acute myocarditis with poor prognosis.
• Further research is warranted to confirm the efficacy and mechanisms of autoimmune treatment in myocarditis.
• This approach could potentially alter the management of severe cardiac inflammatory conditions.